Product Code: ETC057338 | Publication Date: May 2021 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 |
The Asia Pacific (APAC) chemotherapy?market is growing over the years principally due to the increasing incidence of cancer in the Asia-Pacific region is driving the demand for chemotherapy. Additionally, the improvement of healthcare infrastructure in the Asia-Pacific region is leading to greater access to chemotherapy treatments. Moreover, the growing awareness about cancer and its treatments is driving the demand for chemotherapy. Further, the aging population in the Asia-Pacific region is expected to increase the demand for chemotherapy as elderly individuals are more prone to cancer. In addition, the governments in the Asia-Pacific region are investing in healthcare, including cancer treatments, which is expected to drive the growth of the chemotherapy market. Further, some of the current trends in the Asia-Pacific chemotherapy market include the increasing use of targeted therapy, the increasing adoption of biosimilars, and the growing use of immunotherapy in combination with chemotherapy. There are several challenges faced by the Asia Pacific chemotherapy market such as in some regions of the Asia Pacific, there is a lack of awareness about chemotherapy and its benefits, leading to underutilization of this treatment option. Additionally, the high cost of chemotherapy drugs is a major barrier for many patients, particularly in developing countries where the majority of the population lacks adequate health insurance coverage. Moreover, the lack of modern healthcare infrastructure in some parts of the Asia Pacific region, such as rural areas, makes it difficult for patients to access chemotherapy treatment.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Asia Pacific Chemotherapy Market Overview |
3.1 Asia Pacific Regional Macro Economic Indicators |
3.2 Asia Pacific Chemotherapy Market Revenues & Volume, 2020 & 2027F |
3.3 Asia Pacific Chemotherapy Market - Industry Life Cycle |
3.4 Asia Pacific Chemotherapy Market - Porter's Five Forces |
3.5 Asia Pacific Chemotherapy Market Revenues & Volume Share, By Countries, 2020 & 2027F |
3.6 Asia Pacific Chemotherapy Market Revenues & Volume Share, By Drug Class, 2020 & 2027F |
3.7 Asia Pacific Chemotherapy Market Revenues & Volume Share, By Indication, 2020 & 2027F |
3.8 Asia Pacific Chemotherapy Market Revenues & Volume Share, By Route of Drug Administration, 2020 & 2027F |
3.9 Asia Pacific Chemotherapy Market Revenues & Volume Share, By End-Users, 2020 & 2027F |
4 Asia Pacific Chemotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Asia Pacific Chemotherapy Market Trends |
6 Asia Pacific Chemotherapy Market, 2017 - 2027 |
6.1 Asia Pacific Chemotherapy Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
6.2 Asia Pacific Chemotherapy Market, Revenues & Volume, By Indication, 2017 - 2027 |
6.3 Asia Pacific Chemotherapy Market, Revenues & Volume, By Route of Drug Administration, 2017 - 2027 |
6.4 Asia Pacific Chemotherapy Market, Revenues & Volume, By End-Users, 2017 - 2027 |
7 China Chemotherapy Market, 2017 - 2027 |
7.1 China Chemotherapy Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
7.2 China Chemotherapy Market, Revenues & Volume, By Indication, 2017 - 2027 |
7.3 China Chemotherapy Market, Revenues & Volume, By Route of Drug Administration, 2017 - 2027 |
7.4 China Chemotherapy Market, Revenues & Volume, By End-Users, 2017 - 2027 |
8 India Chemotherapy Market, 2017 - 2027 |
8.1 India Chemotherapy Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
8.2 India Chemotherapy Market, Revenues & Volume, By Indication, 2017 - 2027 |
8.3 India Chemotherapy Market, Revenues & Volume, By Route of Drug Administration, 2017 - 2027 |
8.4 India Chemotherapy Market, Revenues & Volume, By End-Users, 2017 - 2027 |
9 Japan Chemotherapy Market, 2017 - 2027 |
9.1 Japan Chemotherapy Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
9.2 Japan Chemotherapy Market, Revenues & Volume, By Indication, 2017 - 2027 |
9.3 Japan Chemotherapy Market, Revenues & Volume, By Route of Drug Administration, 2017 - 2027 |
9.4 Japan Chemotherapy Market, Revenues & Volume, By End-Users, 2017 - 2027 |
10 Australia Chemotherapy Market, 2017 - 2027 |
10.1 Australia Chemotherapy Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
10.2 Australia Chemotherapy Market, Revenues & Volume, By Indication, 2017 - 2027 |
10.3 Australia Chemotherapy Market, Revenues & Volume, By Route of Drug Administration, 2017 - 2027 |
10.4 Australia Chemotherapy Market, Revenues & Volume, By End-Users, 2017 - 2027 |
11 Indonesia Chemotherapy Market, 2017 - 2027 |
11.1 Indonesia Chemotherapy Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
11.2 Indonesia Chemotherapy Market, Revenues & Volume, By Indication, 2017 - 2027 |
11.3 Indonesia Chemotherapy Market, Revenues & Volume, By Route of Drug Administration, 2017 - 2027 |
11.4 Indonesia Chemotherapy Market, Revenues & Volume, By End-Users, 2017 - 2027 |
12 Philippines Chemotherapy Market, 2017 - 2027 |
12.1 Philippines Chemotherapy Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
12.2 Philippines Chemotherapy Market, Revenues & Volume, By Indication, 2017 - 2027 |
12.3 Philippines Chemotherapy Market, Revenues & Volume, By Route of Drug Administration, 2017 - 2027 |
12.4 Philippines Chemotherapy Market, Revenues & Volume, By End-Users, 2017 - 2027 |
13 Thailand Chemotherapy Market, 2017 - 2027 |
13.1 Thailand Chemotherapy Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
13.2 Thailand Chemotherapy Market, Revenues & Volume, By Indication, 2017 - 2027 |
13.3 Thailand Chemotherapy Market, Revenues & Volume, By Route of Drug Administration, 2017 - 2027 |
13.4 Thailand Chemotherapy Market, Revenues & Volume, By End-Users, 2017 - 2027 |
14 Malaysia Chemotherapy Market, 2017 - 2027 |
14.1 Malaysia Chemotherapy Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
14.2 Malaysia Chemotherapy Market, Revenues & Volume, By Indication, 2017 - 2027 |
14.3 Malaysia Chemotherapy Market, Revenues & Volume, By Route of Drug Administration, 2017 - 2027 |
14.4 Malaysia Chemotherapy Market, Revenues & Volume, By End-Users, 2017 - 2027 |
15 Singapore Chemotherapy Market, 2017 - 2027 |
16 Rest of Asia Chemotherapy Market, 2017 - 2027 |
16.1 Rest of Asia Chemotherapy Market, Revenues & Volume, By Drug Class, 2017 - 2027 |
16.2 Rest of Asia Chemotherapy Market, Revenues & Volume, By Indication, 2017 - 2027 |
16.3 Rest of Asia Chemotherapy Market, Revenues & Volume, By Route of Drug Administration, 2017 - 2027 |
16.4 Rest of Asia Chemotherapy Market, Revenues & Volume, By End-Users, 2017 - 2027 |
17 Asia Pacific Chemotherapy Market Key Performance Indicators |
18 Asia Pacific Chemotherapy Market - Opportunity Assessment |
18.1 Asia Pacific Chemotherapy Market Opportunity Assessment, By Countries, 2020 & 2027F |
18.2 Asia Pacific Chemotherapy Market Opportunity Assessment, By Drug Class, 2020 & 2027F |
18.3 Asia Pacific Chemotherapy Market Opportunity Assessment, By Indication, 2020 & 2027F |
18.4 Asia Pacific Chemotherapy Market Opportunity Assessment, By Route of Drug Administration, 2020 & 2027F |
18.5 Asia Pacific Chemotherapy Market Opportunity Assessment, By End-Users, 2020 & 2027F |
19 Asia Pacific Chemotherapy Market - Competitive Landscape |
19.1 Asia Pacific Chemotherapy Market Revenue Share, By Companies, 2020 |
19.2 Asia Pacific Chemotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
20 Company Profiles |
21 Recommendations |
22 Disclaimer |